Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Acupuncture and Doxylamine/Pyridoxine for Moderate to Severe Nausea and Vomiting in Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. Women with 20-45 years of age;~2. PUQE score ≥6;~3. 7-14 weeks of gestation with viable fetus inside the uterine cavity confirmed by ultrasound dating;~4. Less than 20% weight loss.~Exclusion Criteria:~1. Having major medical problems such as malignant tumor, acute or subacute severe hepatitis, severe aplastic anemia, idiopathic thrombocytopenic purpura, acute appendicitis, acute pancreatitis, TORCH syndrome, etc~2. Having chronic medical conditions such as poorly controlled diabetes, coronary heart disease, uncontrolled hypertension, etc~3. Coexistence of other diseases that cause vomiting such as infectious disease, gestational trophoblastic disease, etc~4. Having asthma, increased intraocular pressure, narrow-angle glaucoma, narrow peptic ulcer, pyloric obstruction, bladder neck obstruction, etc~5. Taking antiemetics such as vitamin B6, ondansetron, metoclopramide, prednisone, anti-vomiting Chinese medicine, etc., within the past week~6. Receiving conservative treatment such as dietary and lifestyle modification~7. Abnormal physical examination and laboratory tests (minor abnormalities in laboratory tests due to pregnancy vomiting, such as liver function and ions, are acceptable for inclusion)~8. Having mental handicaps or psychological disorders~9. Allergic to doxylamine, other ethanolamine-derived antihistamines, pyridoxine hydrochloride, or any inactive ingredient in diclectin~10. Using monoamine oxidase inhibitors~11. Driving or operating heavy machinery~12. Using alcohol or other central nervous system inhibitors

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Diclectin plus active acupuncture (Type: OTHER): Diclectin (combination of doxylamine succinate (10 mg) and pyridoxine hydrochloride (10 mg) , 2-4 tablets/day) + active acupuncture (30 min /every day).
- Diclectin plus sham acupuncture (Type: OTHER): Diclectin (combination of doxylamine succinate (10 mg) and pyridoxine hydrochloride (10 mg), 2-4 tablets/day) + sham acupuncture (30 min /every day).
- Placebo plus active acupuncture (Type: OTHER): Diclectin placebo (2-4 tablets/day) + active acupuncture (30 min / every day)
- Placebo plus sham acupuncture (Type: OTHER): Diclectin placebo (2-4 tablets/day) + sham acupuncture (30 min /every day)

Based on this trial design, predict the completion outcome and termination type (if applicable).